EHT 0202
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EHT 0202, covering 2009-09-21 to 2009-09-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease [Phase 2]